SIRE GROUP LTD. enters TITAN PHARMACEUTICALS INC with 20.84M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/4/2023ACC: 0001829126-23-006437
20.84M
Baseline shares
100% direct
20.84M
Direct ownership
1 position
20.84M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned20.84M
Total
20.84M direct20.84M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.84M | Direct |
| Total | 20.84M | 20.84M direct |
Derivative Holdings1
Series AA Convertible Preferred Stock ("Preferred Stock")
DirectUnderlying security
Common Stock
Underlying shares
20.84M
Shares owned
N/A
Exercise price
0.466
Expiration
—
Exercise window
—
Total
Underlying
20.84M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series AA Convertible Preferred Stock ("Preferred Stock") Direct | Common Stock | 0.466 | — | — | 20.84M | N/A |
| Total | 20.84M | 0.00 | ||||